Latest news about Greenphire
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Greenphire and Suvoda have announced a merger to create a unified technology platform for clinical trials, combining patient-centric solutions, trial randomization, supply management, eConsent, eCOA, payments, budgeting, and travel logistics. The merger, expected to close in Q2 2025, will be led by Suvoda's CEO Jagath Wanninayake, with Greenphire's CEO Jim Murphy serving as an advisor[1][4][5].
Greenphire and Suvoda's merger, announced on January 13, 2025, will create a comprehensive clinical trial platform, enhancing patient access and engagement, simplifying site technologies, and supporting pharma and CRO objectives. Thoma Bravo and Bain Capital Tech Opportunities will invest in the combined company[1][3][5].
Greenphire and Suvoda's merger, announced on January 13, 2025, will be supported by investments from Thoma Bravo as the lead strategic investor and a significant minority investment from Bain Capital Tech Opportunities upon closing, expected in Q2 2025[1][3][5].
Open job positions at Greenphire
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Data Analyst II
Accounts Receivable Customer Support Representative
Team Lead, Payment Implementation (King of Prussia, PA)

